Glycans as targets for therapeutic antitumor antibodies
Glycans as targets for therapeutic antitumor antibodies
About this item
Full title
Author / Creator
Publisher
England: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
Glycans represent a vast class of molecules that modify either proteins or lipids. They exert and regulate important and complex functions in both normal and cancer cell metabolism. As such, the most immunogenic glycans have been targeted in passive and active immunotherapy in human cancer for the past 25 years but it is only recently that techniqu...
Alternative Titles
Full title
Glycans as targets for therapeutic antitumor antibodies
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1034197239
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1034197239
Other Identifiers
ISSN
1479-6694
E-ISSN
1744-8301
DOI
10.2217/fon.12.88
